IMCR logo

Immunocore Holdings (IMCR) Cash from operations

annual CFO:

$26.06M+$23.12M(+786.43%)
December 31, 2024

Summary

  • As of today (June 28, 2025), IMCR annual cash flow from operations is $26.06 million, with the most recent change of +$23.12 million (+786.43%) on December 31, 2024.
  • During the last 3 years, IMCR annual CFO has risen by +$169.17 million (+118.21%).
  • IMCR annual CFO is now at all-time high.

Performance

IMCR Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMCRcash flow metrics

quarterly CFO:

$435.00K+$14.39M(+103.12%)
March 31, 2025

Summary

  • As of today (June 28, 2025), IMCR quarterly cash flow from operations is $435.00 thousand, with the most recent change of +$14.39 million (+103.12%) on March 31, 2025.
  • Over the past year, IMCR quarterly CFO has increased by +$5.02 million (+109.48%).
  • IMCR quarterly CFO is now -98.15% below its all-time high of $23.47 million, reached on June 30, 2024.

Performance

IMCR quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMCRcash flow metrics

TTM CFO:

$31.08M+$5.02M(+19.27%)
March 31, 2025

Summary

  • As of today (June 28, 2025), IMCR TTM cash flow from operations is $31.08 million, with the most recent change of +$5.02 million (+19.27%) on March 31, 2025.
  • Over the past year, IMCR TTM CFO has increased by +$43.27 million (+355.07%).
  • IMCR TTM CFO is now at all-time high.

Performance

IMCR TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMCRcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

IMCR Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+786.4%+109.5%+355.1%
3 y3 years+118.2%+101.1%+121.0%
5 y5 years+119.3%+101.2%+182.3%

IMCR Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+118.2%-98.2%+101.1%at high+121.0%
5 y5-yearat high+118.2%-98.2%+101.0%at high+121.0%
alltimeall timeat high+118.2%-98.2%+101.0%at high+121.0%

IMCR Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
$435.00K(-103.1%)
$31.08M(+19.3%)
Dec 2024
$26.06M(+786.4%)
-$13.95M(-166.0%)
$26.06M(+17.0%)
Sep 2024
-
$21.13M(-10.0%)
$22.28M(+98.2%)
Jun 2024
-
$23.47M(-611.7%)
$11.24M(-192.2%)
Mar 2024
-
-$4.59M(-74.1%)
-$12.19M(-514.5%)
Dec 2023
$2.94M(-106.0%)
-$17.73M(-275.8%)
$2.94M(-58.7%)
Sep 2023
-
$10.09M(>+9900.0%)
$7.11M(-28.2%)
Jun 2023
-
$45.00K(-99.6%)
$9.91M(+441.0%)
Mar 2023
-
$10.54M(-177.7%)
$1.83M(-103.7%)
Dec 2022
-$49.21M
-$13.56M(-205.2%)
-$49.21M(-31.3%)
Sep 2022
-
$12.89M(-260.4%)
-$71.64M(-35.2%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$8.03M(-80.2%)
-$110.57M(-25.2%)
Mar 2022
-
-$40.50M(+12.5%)
-$147.90M(+3.3%)
Dec 2021
-$143.11M(+71.4%)
-$35.99M(+38.2%)
-$143.11M(+3.5%)
Sep 2021
-
-$26.05M(-42.6%)
-$138.27M(+20.7%)
Jun 2021
-
-$45.36M(+27.0%)
-$114.51M(+40.6%)
Mar 2021
-
-$35.71M(+14.6%)
-$81.43M(-2.4%)
Dec 2020
-$83.47M(-38.1%)
-$31.15M(+1258.9%)
-$83.47M(+59.5%)
Sep 2020
-
-$2.29M(-81.3%)
-$52.32M(+4.6%)
Jun 2020
-
-$12.28M(-67.5%)
-$50.03M(+32.5%)
Mar 2020
-
-$37.75M
-$37.75M
Dec 2019
-$134.92M(+539.5%)
-
-
Dec 2018
-$21.10M
-
-

FAQ

  • What is Immunocore Holdings annual cash flow from operations?
  • What is the all time high annual CFO for Immunocore Holdings?
  • What is Immunocore Holdings annual CFO year-on-year change?
  • What is Immunocore Holdings quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Immunocore Holdings?
  • What is Immunocore Holdings quarterly CFO year-on-year change?
  • What is Immunocore Holdings TTM cash flow from operations?
  • What is the all time high TTM CFO for Immunocore Holdings?
  • What is Immunocore Holdings TTM CFO year-on-year change?

What is Immunocore Holdings annual cash flow from operations?

The current annual CFO of IMCR is $26.06M

What is the all time high annual CFO for Immunocore Holdings?

Immunocore Holdings all-time high annual cash flow from operations is $26.06M

What is Immunocore Holdings annual CFO year-on-year change?

Over the past year, IMCR annual cash flow from operations has changed by +$23.12M (+786.43%)

What is Immunocore Holdings quarterly cash flow from operations?

The current quarterly CFO of IMCR is $435.00K

What is the all time high quarterly CFO for Immunocore Holdings?

Immunocore Holdings all-time high quarterly cash flow from operations is $23.47M

What is Immunocore Holdings quarterly CFO year-on-year change?

Over the past year, IMCR quarterly cash flow from operations has changed by +$5.02M (+109.48%)

What is Immunocore Holdings TTM cash flow from operations?

The current TTM CFO of IMCR is $31.08M

What is the all time high TTM CFO for Immunocore Holdings?

Immunocore Holdings all-time high TTM cash flow from operations is $31.08M

What is Immunocore Holdings TTM CFO year-on-year change?

Over the past year, IMCR TTM cash flow from operations has changed by +$43.27M (+355.07%)
On this page